Nick Galakatos
InvestorGlobal Head of Blackstone Life Sciences at Blackstone Life Sciences
About
Global Head of Blackstone Life Sciences, known for a differentiated approach to life sciences investing and risk mitigation.
Contact· self-published, not guessed
Invests in
BiotechHealthtechMedical Devices
Investments
Board seats
Anthos TherapeuticsBioMed RealtyNeurvatiTransForm Pharmaceuticals
Per the firm's website.
Colleagues at Blackstone Life Sciences
Ari Brettman
Senior Managing Director at Blackstone Life Sciences
Barry Gertz
Managing Director at Blackstone Life Sciences
Colm Foley
Managing Director at Blackstone Life Sciences
Dylan Goldstein
Vice President at Blackstone Life Sciences
Kiran Reddy
Senior Managing Director at Blackstone Life Sciences
M. Craig Shepherd
Senior Managing Director at Blackstone Life Sciences
Paris Panayiotopoulos
Senior Managing Director at Blackstone Life Sciences
Robert Liptak
Senior Managing Director at Blackstone Life Sciences
Frequently asked questions
- Who is Nick Galakatos?
- Global Head of Blackstone Life Sciences, known for a differentiated approach to life sciences investing and risk mitigation.
- Where does Nick Galakatos work?
- Nick Galakatos is Global Head of Blackstone Life Sciences at Blackstone Life Sciences.
- What does Nick Galakatos invest in?
- Nick Galakatos invests in Biotech, Healthtech, Medical Devices.
- What boards does Nick Galakatos sit on?
- Nick Galakatos holds tracked board seats at Anthos Therapeutics, BioMed Realty, Neurvati, TransForm Pharmaceuticals.